stbt
2021-07-06
Fly fly 🪰
BRIEF-Bionano Genomics Announces Significant Progress In China With Wehealth Shanghai’S Adoption Of Bionano’S Saphyr System<blockquote>BRIEF-Bionano Genomics宣布在中国取得重大进展，Wehealth Shanghai采用Bionano的Saphyr系统</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":157836293,"tweetId":"157836293","gmtCreate":1625577106712,"gmtModify":1631888656173,"author":{"id":3586559724369363,"idStr":"3586559724369363","authorId":3586559724369363,"authorIdStr":"3586559724369363","name":"stbt","avatar":"https://static.tigerbbs.com/5eb8c0de0c15ddfac72b805fb711fb00","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Fly fly 🪰 </p></body></html>","htmlText":"<html><head></head><body><p>Fly fly 🪰 </p></body></html>","text":"Fly fly 🪰","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/157836293","repostId":2149350024,"repostType":2,"repost":{"id":"2149350024","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625575193,"share":"https://www.laohu8.com/m/news/2149350024?lang=zh_CN&edition=full","pubTime":"2021-07-06 20:39","market":"us","language":"en","title":"BRIEF-Bionano Genomics Announces Significant Progress In China With Wehealth Shanghai’S Adoption Of Bionano’S Saphyr System<blockquote>BRIEF-Bionano Genomics宣布在中国取得重大进展，Wehealth Shanghai采用Bionano的Saphyr系统</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2149350024","media":"Reuters","summary":"July 6 (Reuters) - Bionano Genomics Inc : * BIONANO GENOMICS ANNOUNCES SIGNIFICANT PROGRESS IN C","content":"<p><html><body>July 6 (Reuters) - <a href=\"https://laohu8.com/S/BNGOU\">Bionano Genomics Inc</a> :</p><p><blockquote><html><body>路透7月6日-<a href=\"https://laohu8.com/S/BNGOU\">生物纳米基因组学公司</a>：</body></html></blockquote></p><p> * BIONANO GENOMICS ANNOUNCES SIGNIFICANT PROGRESS IN CHINA WITH WEHEALTH SHANGHAI’S ADOPTION OF BIONANO’S SAPHYR SYSTEM AND THE DEMONSTRATION BY VARIOUS INSTITUTIONS OF OPTICAL GENOME MAPPING IN REPRODUCTIVE HEALTH AND GENETICS</p><p><blockquote>*BIONANO GENOMICS宣布在中国取得重大进展，WEHEALTH SHANGHAI采用BIONANO的SAPHYR系统，并在生殖健康和遗传学领域得到多家机构的演示</blockquote></p><p>Source text for Eikon: Further company coverage: </p><p><blockquote>Eikon的源文本：更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bionano Genomics Announces Significant Progress In China With Wehealth Shanghai’S Adoption Of Bionano’S Saphyr System<blockquote>BRIEF-Bionano Genomics宣布在中国取得重大进展，Wehealth Shanghai采用Bionano的Saphyr系统</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bionano Genomics Announces Significant Progress In China With Wehealth Shanghai’S Adoption Of Bionano’S Saphyr System<blockquote>BRIEF-Bionano Genomics宣布在中国取得重大进展，Wehealth Shanghai采用Bionano的Saphyr系统</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2021-07-06 20:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body>July 6 (Reuters) - <a href=\"https://laohu8.com/S/BNGOU\">Bionano Genomics Inc</a> :</p><p><blockquote><html><body>路透7月6日-<a href=\"https://laohu8.com/S/BNGOU\">生物纳米基因组学公司</a>：</body></html></blockquote></p><p> * BIONANO GENOMICS ANNOUNCES SIGNIFICANT PROGRESS IN CHINA WITH WEHEALTH SHANGHAI’S ADOPTION OF BIONANO’S SAPHYR SYSTEM AND THE DEMONSTRATION BY VARIOUS INSTITUTIONS OF OPTICAL GENOME MAPPING IN REPRODUCTIVE HEALTH AND GENETICS</p><p><blockquote>*BIONANO GENOMICS宣布在中国取得重大进展，WEHEALTH SHANGHAI采用BIONANO的SAPHYR系统，并在生殖健康和遗传学领域得到多家机构的演示</blockquote></p><p>Source text for Eikon: Further company coverage: </p><p><blockquote>Eikon的源文本：更多公司报道：</blockquote></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p><p><blockquote>（（Reuters.Briefs@thomsonreuters.com；））</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRGS":"Progress Software Corporation","BNGO":"Bionano Genomics","CAAS":"中汽系统"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149350024","content_text":"July 6 (Reuters) - Bionano Genomics Inc : * BIONANO GENOMICS ANNOUNCES SIGNIFICANT PROGRESS IN CHINA WITH WEHEALTH SHANGHAI’S ADOPTION OF BIONANO’S SAPHYR SYSTEM AND THE DEMONSTRATION BY VARIOUS INSTITUTIONS OF OPTICAL GENOME MAPPING IN REPRODUCTIVE HEALTH AND GENETICSSource text for Eikon: Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"BNGO":1,"PRGS":1,"CAAS":1}},"isVote":1,"tweetType":1,"viewCount":449,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/157836293"}
精彩评论